By Tim - http://stockstobuy.org
Shares of Anadys Pharmaceuticals, Inc. (ANDS) are exploding higher in early trading this morning as the company has released positive Hepatitis C data. $3.25 Up 25%
72% OF PATIENTS RECEIVING ANA598 IN PHASE II COMBINATION STUDY WITH INTERFERON AND RIBAVIRIN ACHIEVE UNDETECTABLE LEVELS OF VIRUS AT WEEK EIGHT
Absence of Viral Breakthrough and Favorable Safety Profile Confirm Previous Results
April 15, 2010 - Anadys Pharmaceuticals, Inc. announced today that 72% of hepatitis C patients receiving ANA598 400 mg twice daily (bid) plus standard of care (SOC)achieved undetectable levels of virus at week eight in an ongoing Phase II study, compared to 38% of patients receiving placebo plus SOC.
The preliminary analysis of results through eight weeks also showed that ANA598 400 mg bid plus SOC was well tolerated, with an adverse event profile comparable to SOC alone. As seen before at 200 mg bid, no patient experienced viral breakthrough on ANA598.
Full Article - Here
Today's Biggest Stock Market Gainers - Top 2010 Stock Gainers - Top 2010 Penny Stocks - Top 2009 Stock Gainers - Top 2009 Penny Stocks - Hot OTC Stocks - Stocks for 2010
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Showing posts with label anadys pharmaceuticals. Show all posts
Showing posts with label anadys pharmaceuticals. Show all posts
Thursday, April 15, 2010
Tuesday, January 13, 2009
Top Stocks 2009 - Anady's ( ANDS ) Pharmaceuticals
2009 is starting out with a big bang as the Top Stocks 2009 List is continuing to grow with promising companies. While all the major stock market averages are down for the year, there is one stock to watch so far in 2009. You can find the best stocks in 2009 list Right Here.
Anady's Pharmaceuticals ( ANDS ) - $4.28 Up 172% in 2009 - Anady's ( ANDS ) is exploding in 2009 on huge news. Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) today announced results from the first cohort of an ongoing Phase Ib clinical trial of ANA598, the Company's investigational non-nucleoside polymerase inhibitor. ANA598 was very well-tolerated and demonstrated potent antiviral activity in patients infected with chronic Hepatitis C virus (HCV) in this first cohort of the study - LINK
About Anadys Pharmaceuticals -ANDS is a bio pharmaceutical company, engages in developing medicines in the areas of hepatitis C and oncology. It develops ANA598, a small-molecule non-nucleoside inhibitor of the NS5B polymerase for the treatment of hepatitis C; and ANA773, an oral toll-like receptor 7 agonist prodrug for cancer. The company was founded in 1992. It was formerly known as ScripTech Pharmaceuticals, Inc. and changed its name to Scriptgen Pharmaceuticals, Inc. in 1994. Later, the company changed its name to Anadys Pharmaceuticals, Inc. in 2000. Anadys Pharmaceuticals is headquartered in San Diego, California.
Merriman Curhan Ford covers ANDS stock with a Buy Rating - January 8, 2009
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Anady's Pharmaceuticals ( ANDS ) - $4.28 Up 172% in 2009 - Anady's ( ANDS ) is exploding in 2009 on huge news. Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) today announced results from the first cohort of an ongoing Phase Ib clinical trial of ANA598, the Company's investigational non-nucleoside polymerase inhibitor. ANA598 was very well-tolerated and demonstrated potent antiviral activity in patients infected with chronic Hepatitis C virus (HCV) in this first cohort of the study - LINK
About Anadys Pharmaceuticals -ANDS is a bio pharmaceutical company, engages in developing medicines in the areas of hepatitis C and oncology. It develops ANA598, a small-molecule non-nucleoside inhibitor of the NS5B polymerase for the treatment of hepatitis C; and ANA773, an oral toll-like receptor 7 agonist prodrug for cancer. The company was founded in 1992. It was formerly known as ScripTech Pharmaceuticals, Inc. and changed its name to Scriptgen Pharmaceuticals, Inc. in 1994. Later, the company changed its name to Anadys Pharmaceuticals, Inc. in 2000. Anadys Pharmaceuticals is headquartered in San Diego, California.
Merriman Curhan Ford covers ANDS stock with a Buy Rating - January 8, 2009
For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free
Subscribe to:
Posts (Atom)